Chinese Journal of Chromatography ›› 2025, Vol. 43 ›› Issue (6): 620-629.DOI: 10.3724/SP.J.1123.2024.10031
• Articles • Previous Articles Next Articles
BAO Dejun, FENG Zhuangzhuang, ZHANG Xu, SUN Qi, ZHANG Zhuona, HU Xiaojian, ZHU Ying*(), LIN Xiao*(
)
Received:
2024-10-29
Online:
2025-06-08
Published:
2025-05-21
Supported by:
CLC Number:
BAO Dejun, FENG Zhuangzhuang, ZHANG Xu, SUN Qi, ZHANG Zhuona, HU Xiaojian, ZHU Ying, LIN Xiao. Determination of 22 organic ultraviolet absorbers in human serum by ultra performance liquid chromatography- tandem mass spectrometry[J]. Chinese Journal of Chromatography, 2025, 43(6): 620-629.
Compound | Retention time/min | Parent ion (m/z) | Daughter ions (m/z) | CV/V | CEs/eV | Internal standard |
---|---|---|---|---|---|---|
4′-Methoxyacetophenone (4′-MAP) | 5.57 | 151.1 | 42.9*, 93.9 | 18 | 12, 20 | EHMC-D3 |
2,2′,4,4′-Tetrahydroxybenzophenone (BP-2) | 5.59 | 245.0 | 91.0, 135.0* | ‒10 | ‒28, ‒16 | BP-2-D4 |
4-Hydroxybenzophenone (4-OHBP) | 6.67 | 196.9 | 91.9*, 120.1 | ‒10 | ‒26, ‒24 | 4-OHBP-D4 |
2,2′-Dihydroxy-4-methoxybenzophenone (BP-8) | 6.72 | 243.9 | 93.1*, 123.5 | ‒20 | ‒22, ‒16 | BP-8-D3 |
2,4-Dihydroxybenzophenone (BP-1) | 6.89 | 212.9 | 91.0, 135.0* | ‒16 | ‒24, ‒20 | BP-1-D5 |
Oxybenzone (BP-3) | 7.42 | 227.1 | 167.0, 211.2* | ‒8 | ‒34, ‒16 | BP-3-D3 |
3-Benzylidene camphor (3-BC) | 8.29 | 241.2 | 91.0*, 157.1 | 10 | 32, 16 | 4-MBC-D4 |
2-(2-Hydroxy-5-methylphenyl)benzotriazole (UV-P) | 8.65 | 226.1 | 107.0, 120.0* | 12 | 20, 18 | UV-P-D3 |
4-Methylbenzylidene camphor (4-MBC) | 9.07 | 259.1 | 97.1, 105.0* | 28 | 18, 26 | 4-MBC-D4 |
Diethylaminohydroxybenzoylhexyl benzoate (DHHB) | 9.57 | 398.3 | 148.9*, 233.2 | 30 | 18, 10 | OC-13C3 |
Octocrylene (OC) | 10.77 | 362.5 | 232.3*, 250.1 | 20 | 20, 20 | OC-13C3 |
2-Cyano-3,3-diphenylpropenoic acid (CDAA) | 10.78 | 250.0 | 201.0, 207.0* | 20 | 25, 15 | OC-13C3 |
Avobenzone (AVO) | 11.75 | 310.9 | 134.9, 161.2* | 20 | 20, 20 | AVO-13CD |
Ethylhexyl methoxycinnamate (EHMC) | 11.76 | 290.9 | 160.8*, 179.1 | 16 | 12, 12 | EHMC-D3 |
4-Methoxycinnamic acid (4-MCA) | 11.77 | 178.9 | 132.9*, 117.9 | 18 | 18, 24 | EHMC-D3 |
Ethylhexyl salicylate (EHS) | 11.96 | 249.0 | 93.0, 249.0* | ‒15 | ‒5, ‒22 | EHS-D4 |
Homosalate (HMS) | 12.04 | 261.0 | 93.0, 137.0* | ‒18 | ‒18, ‒18 | HMS-D4 |
2-(2H-Benzotriazol-2-yl)-4-methyl-6-(2-propenyl)phenol (UV-9) | 12.06 | 266.3 | 119.0*, 147.0 | 15 | 18, 16 | EHS-D4 |
2-(2′-Hydroxy-5′-(1-1-3-3-tetramethylbutyl)phenyl)benzotriazole (UV-329) | 12.46 | 324.2 | 57.0, 212.1* | 4 | 26, 22 | UV-329-13C6 |
2-(5-Chlor-2H-benzotriazol-2-yl)-6-(1,1-dimethylethyl)-4-methyl-phenol (UV-326) | 13.04 | 316.1 | 57.0, 106.9* | 50 | 24, 24 | UV-326-D3 |
2-(2H-Benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) | 13.26 | 352.2 | 71.1, 282.3* | 22 | 25, 21 | UV-328-D12 |
2,4-Bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine (BEMT) | 19.29 | 628.3 | 136.0*, 404.1 | 14 | 54, 42 | EHMC-D3 |
BP-2-D4 | 5.56 | 249.1 | 110.9 | ‒16 | ‒4 | / |
4-OHBP-D4 | 6.66 | 200.9 | 95.8 | ‒30 | ‒6 | / |
BP-8-D3 | 6.71 | 246.1 | 125.9 | ‒20 | ‒18 | / |
BP-1-D5 | 6.89 | 218.1 | 134.9 | ‒20 | ‒36 | / |
BP-3-D3 | 7.42 | 230.0 | 166.9 | ‒16 | ‒44 | / |
UV-P-D3 | 8.63 | 229.0 | 81.9 | 2 | 26 | / |
4-MBC-D4 | 9.02 | 259.1 | 98.1 | 26 | 18 | / |
OC-13C3 | 10.71 | 364.9 | 252.9 | 40 | 18 | / |
EHMC-D3 | 11.76 | 293.9 | 181.9 | 14 | 8 | / |
AVO-13CD | 11.79 | 315.1 | 161.0 | 6 | 24 | / |
EHS-D4 | 11.95 | 252.9 | 140.9 | ‒20 | ‒18 | / |
HMS-D4 | 12.03 | 264.9 | 140.9 | ‒16 | ‒18 | / |
UV-329-13C6 | 12.44 | 330.2 | 56.9 | 56 | 24 | / |
UV-326-D3 | 13.01 | 319.0 | 263.0 | 4 | 18 | / |
UV-328-D12 | 13.22 | 364.3 | 289.3 | 2 | 24 | / |
Table 1 MS parameters of the 22 organic ultraviolet absorbers (OUVs) and 15 internal standards
Compound | Retention time/min | Parent ion (m/z) | Daughter ions (m/z) | CV/V | CEs/eV | Internal standard |
---|---|---|---|---|---|---|
4′-Methoxyacetophenone (4′-MAP) | 5.57 | 151.1 | 42.9*, 93.9 | 18 | 12, 20 | EHMC-D3 |
2,2′,4,4′-Tetrahydroxybenzophenone (BP-2) | 5.59 | 245.0 | 91.0, 135.0* | ‒10 | ‒28, ‒16 | BP-2-D4 |
4-Hydroxybenzophenone (4-OHBP) | 6.67 | 196.9 | 91.9*, 120.1 | ‒10 | ‒26, ‒24 | 4-OHBP-D4 |
2,2′-Dihydroxy-4-methoxybenzophenone (BP-8) | 6.72 | 243.9 | 93.1*, 123.5 | ‒20 | ‒22, ‒16 | BP-8-D3 |
2,4-Dihydroxybenzophenone (BP-1) | 6.89 | 212.9 | 91.0, 135.0* | ‒16 | ‒24, ‒20 | BP-1-D5 |
Oxybenzone (BP-3) | 7.42 | 227.1 | 167.0, 211.2* | ‒8 | ‒34, ‒16 | BP-3-D3 |
3-Benzylidene camphor (3-BC) | 8.29 | 241.2 | 91.0*, 157.1 | 10 | 32, 16 | 4-MBC-D4 |
2-(2-Hydroxy-5-methylphenyl)benzotriazole (UV-P) | 8.65 | 226.1 | 107.0, 120.0* | 12 | 20, 18 | UV-P-D3 |
4-Methylbenzylidene camphor (4-MBC) | 9.07 | 259.1 | 97.1, 105.0* | 28 | 18, 26 | 4-MBC-D4 |
Diethylaminohydroxybenzoylhexyl benzoate (DHHB) | 9.57 | 398.3 | 148.9*, 233.2 | 30 | 18, 10 | OC-13C3 |
Octocrylene (OC) | 10.77 | 362.5 | 232.3*, 250.1 | 20 | 20, 20 | OC-13C3 |
2-Cyano-3,3-diphenylpropenoic acid (CDAA) | 10.78 | 250.0 | 201.0, 207.0* | 20 | 25, 15 | OC-13C3 |
Avobenzone (AVO) | 11.75 | 310.9 | 134.9, 161.2* | 20 | 20, 20 | AVO-13CD |
Ethylhexyl methoxycinnamate (EHMC) | 11.76 | 290.9 | 160.8*, 179.1 | 16 | 12, 12 | EHMC-D3 |
4-Methoxycinnamic acid (4-MCA) | 11.77 | 178.9 | 132.9*, 117.9 | 18 | 18, 24 | EHMC-D3 |
Ethylhexyl salicylate (EHS) | 11.96 | 249.0 | 93.0, 249.0* | ‒15 | ‒5, ‒22 | EHS-D4 |
Homosalate (HMS) | 12.04 | 261.0 | 93.0, 137.0* | ‒18 | ‒18, ‒18 | HMS-D4 |
2-(2H-Benzotriazol-2-yl)-4-methyl-6-(2-propenyl)phenol (UV-9) | 12.06 | 266.3 | 119.0*, 147.0 | 15 | 18, 16 | EHS-D4 |
2-(2′-Hydroxy-5′-(1-1-3-3-tetramethylbutyl)phenyl)benzotriazole (UV-329) | 12.46 | 324.2 | 57.0, 212.1* | 4 | 26, 22 | UV-329-13C6 |
2-(5-Chlor-2H-benzotriazol-2-yl)-6-(1,1-dimethylethyl)-4-methyl-phenol (UV-326) | 13.04 | 316.1 | 57.0, 106.9* | 50 | 24, 24 | UV-326-D3 |
2-(2H-Benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) | 13.26 | 352.2 | 71.1, 282.3* | 22 | 25, 21 | UV-328-D12 |
2,4-Bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine (BEMT) | 19.29 | 628.3 | 136.0*, 404.1 | 14 | 54, 42 | EHMC-D3 |
BP-2-D4 | 5.56 | 249.1 | 110.9 | ‒16 | ‒4 | / |
4-OHBP-D4 | 6.66 | 200.9 | 95.8 | ‒30 | ‒6 | / |
BP-8-D3 | 6.71 | 246.1 | 125.9 | ‒20 | ‒18 | / |
BP-1-D5 | 6.89 | 218.1 | 134.9 | ‒20 | ‒36 | / |
BP-3-D3 | 7.42 | 230.0 | 166.9 | ‒16 | ‒44 | / |
UV-P-D3 | 8.63 | 229.0 | 81.9 | 2 | 26 | / |
4-MBC-D4 | 9.02 | 259.1 | 98.1 | 26 | 18 | / |
OC-13C3 | 10.71 | 364.9 | 252.9 | 40 | 18 | / |
EHMC-D3 | 11.76 | 293.9 | 181.9 | 14 | 8 | / |
AVO-13CD | 11.79 | 315.1 | 161.0 | 6 | 24 | / |
EHS-D4 | 11.95 | 252.9 | 140.9 | ‒20 | ‒18 | / |
HMS-D4 | 12.03 | 264.9 | 140.9 | ‒16 | ‒18 | / |
UV-329-13C6 | 12.44 | 330.2 | 56.9 | 56 | 24 | / |
UV-326-D3 | 13.01 | 319.0 | 263.0 | 4 | 18 | / |
UV-328-D12 | 13.22 | 364.3 | 289.3 | 2 | 24 | / |
Fig. 1 MRM chromatograms for the mixed standard solution of the 22 OUVs (50 ng/mL)1. 4′-MAP; 2. BP-2; 3. 4-OHBP; 4. BP-8; 5. BP-1; 6. BP-3; 7. 3-BC; 8. UV-P; 9. 4-MBC; 10. DHHB; 11. OC; 12. CDAA; 13. AVO; 14. EHMC; 15. 4-MCA; 16. EHS; 17. HMS; 18. UV-9; 19. UV-329; 20. UV-326; 21. UV-328; 22. BEMT.
Compound | Linear equation | Linear range/(ng/mL) | r | MDL/(ng/mL) | MQL/(ng/mL) |
---|---|---|---|---|---|
EHS | Y=0.9996X+0.0653 | 0.33‒50 | 0.9996 | 0.10 | 0.33 |
HMS | Y=0.0413X+0.0291 | 0.17‒50 | 0.9997 | 0.08 | 0.17 |
EHMC | Y=0.0279X+0.0012 | 0.17‒50 | 0.9999 | 0.09 | 0.17 |
4′-MAP | Y=0.1410X+0.0509 | 0.49‒50 | 0.9998 | 0.15 | 0.49 |
4-MCA | Y=0.0492X+0.0059 | 0.12‒50 | 0.9997 | 0.10 | 0.12 |
AVO | Y=0.1362X+0.0243 | 0.05‒50 | 0.9999 | 0.02 | 0.05 |
OC | Y=0.0351X+0.0003 | 0.37‒50 | 0.9997 | 0.20 | 0.37 |
CDAA | Y=0.0001X+0.0003 | 1.60‒50 | 0.9997 | 0.48 | 1.60 |
4-MBC | Y=0.3431X+0.1090 | 0.26‒50 | 0.9999 | 0.08 | 0.26 |
3-BC | Y=0.4006X+0.0419 | 0.09‒50 | 0.9996 | 0.03 | 0.09 |
UV-P | Y=0.1367X+0.0364 | 0.27‒50 | 0.9999 | 0.12 | 0.27 |
UV-9 | Y=1.5741X+0.2905 | 0.01‒50 | 0.9993 | 0.06 | 0.19 |
UV-326 | Y=0.0154X+0.0095 | 0.25‒50 | 0.9998 | 0.10 | 0.25 |
UV-328 | Y=0.4156X+0.2289 | 0.15‒50 | 0.9996 | 0.04 | 0.15 |
UV-329 | Y=0.2146X+0.1733 | 0.23‒50 | 0.9995 | 0.07 | 0.23 |
BP-1 | Y=0.0482X+0.0128 | 0.12‒50 | 0.9999 | 0.08 | 0.12 |
BP-2 | Y=0.0992X+0.0121 | 0.02‒50 | 0.9999 | 0.02 | 0.02 |
BP-3 | Y=1.2280X+0.2927 | 0.09‒50 | 0.9999 | 0.03 | 0.09 |
BP-8 | Y=0.0041X+0.0121 | 0.15‒50 | 0.9999 | 0.13 | 0.15 |
4-OHBP | Y=0.0535X+0.1349 | 0.30‒50 | 0.9999 | 0.09 | 0.30 |
BEMT | Y=0.0492X+0.0384 | 0.32‒50 | 0.9996 | 0.14 | 0.32 |
DHHB | Y=0.8267X+0.5613 | 0.11‒50 | 0.9996 | 0.03 | 0.11 |
Table 2 Linear equations, linear ranges, correlation coefficients (r), method detection limits (MDLs), and method quantification limits (MQLs) of the 22 OUVs
Compound | Linear equation | Linear range/(ng/mL) | r | MDL/(ng/mL) | MQL/(ng/mL) |
---|---|---|---|---|---|
EHS | Y=0.9996X+0.0653 | 0.33‒50 | 0.9996 | 0.10 | 0.33 |
HMS | Y=0.0413X+0.0291 | 0.17‒50 | 0.9997 | 0.08 | 0.17 |
EHMC | Y=0.0279X+0.0012 | 0.17‒50 | 0.9999 | 0.09 | 0.17 |
4′-MAP | Y=0.1410X+0.0509 | 0.49‒50 | 0.9998 | 0.15 | 0.49 |
4-MCA | Y=0.0492X+0.0059 | 0.12‒50 | 0.9997 | 0.10 | 0.12 |
AVO | Y=0.1362X+0.0243 | 0.05‒50 | 0.9999 | 0.02 | 0.05 |
OC | Y=0.0351X+0.0003 | 0.37‒50 | 0.9997 | 0.20 | 0.37 |
CDAA | Y=0.0001X+0.0003 | 1.60‒50 | 0.9997 | 0.48 | 1.60 |
4-MBC | Y=0.3431X+0.1090 | 0.26‒50 | 0.9999 | 0.08 | 0.26 |
3-BC | Y=0.4006X+0.0419 | 0.09‒50 | 0.9996 | 0.03 | 0.09 |
UV-P | Y=0.1367X+0.0364 | 0.27‒50 | 0.9999 | 0.12 | 0.27 |
UV-9 | Y=1.5741X+0.2905 | 0.01‒50 | 0.9993 | 0.06 | 0.19 |
UV-326 | Y=0.0154X+0.0095 | 0.25‒50 | 0.9998 | 0.10 | 0.25 |
UV-328 | Y=0.4156X+0.2289 | 0.15‒50 | 0.9996 | 0.04 | 0.15 |
UV-329 | Y=0.2146X+0.1733 | 0.23‒50 | 0.9995 | 0.07 | 0.23 |
BP-1 | Y=0.0482X+0.0128 | 0.12‒50 | 0.9999 | 0.08 | 0.12 |
BP-2 | Y=0.0992X+0.0121 | 0.02‒50 | 0.9999 | 0.02 | 0.02 |
BP-3 | Y=1.2280X+0.2927 | 0.09‒50 | 0.9999 | 0.03 | 0.09 |
BP-8 | Y=0.0041X+0.0121 | 0.15‒50 | 0.9999 | 0.13 | 0.15 |
4-OHBP | Y=0.0535X+0.1349 | 0.30‒50 | 0.9999 | 0.09 | 0.30 |
BEMT | Y=0.0492X+0.0384 | 0.32‒50 | 0.9996 | 0.14 | 0.32 |
DHHB | Y=0.8267X+0.5613 | 0.11‒50 | 0.9996 | 0.03 | 0.11 |
Compound | N | DR/% | Minimum/(ng/mL) | Maximum/(ng/mL) | Percentile levels /(ng/mL) | ||
---|---|---|---|---|---|---|---|
5th | 50th | 95th | |||||
4′-MAP | 17 | 15.5 | <MQL | <MQL | <MQL | <MQL | <MQL |
4-MCA | 31 | 28.2 | <MQL | 1.2 | <MQL | <MQL | 0.4 |
UV-P | 72 | 65.5 | <MQL | 9.4 | <MQL | 0.2 | 3.0 |
CDAA | 9 | 8.2 | <MQL | 11.7 | <MQL | <MQL | 2.7 |
EHMC | 6 | 5.5 | <MQL | 0.9 | <MQL | <MQL | 0.2 |
UV-326 | 27 | 24.6 | <MQL | 8.7 | <MQL | <MQL | <MQL |
UV-329 | 7 | 6.4 | <MQL | 1.4 | <MQL | <MQL | 0.5 |
UV-328 | 1 | 0.9 | <MQL | <MQL | <MQL | <MQL | <MQL |
OC | 12 | 10.9 | <MQL | 9.8 | <MQL | <MQL | 2.6 |
DHHB | 16 | 14.6 | <MQL | 0.1 | <MQL | <MQL | <MQL |
BEMT | 3 | 2.7 | <MQL | 0.6 | <MQL | <MQL | <MQL |
EHS | 49 | 44.6 | <MQL | 5.8 | <MQL | <MQL | 4.3 |
HMS | 10 | 9.1 | <MQL | 0.6 | <MQL | <MQL | <MQL |
AVO | 29 | 26.4 | <MQL | 2.7 | <MQL | <MQL | <MQL |
4-OHBP | 1 | 0.9 | <MQL | <MQL | <MQL | <MQL | <MQL |
BP-3 | 12 | 10.9 | <MQL | 0.3 | <MQL | <MQL | <MQL |
BP-8 | 0 | 0 | / | / | / | / | / |
BP-2 | 1 | 0.9 | <MQL | <MQL | <MQL | <MQL | <MQL |
4-MBC | 0 | 0 | / | / | / | / | / |
UV-9 | 0 | 0 | / | / | / | / | / |
BP-1 | 0 | 0 | / | / | / | / | / |
3-BC | 0 | 0 | / | / | / | / | / |
Table 3 Determination results of the 22 OUVs in human serum
Compound | N | DR/% | Minimum/(ng/mL) | Maximum/(ng/mL) | Percentile levels /(ng/mL) | ||
---|---|---|---|---|---|---|---|
5th | 50th | 95th | |||||
4′-MAP | 17 | 15.5 | <MQL | <MQL | <MQL | <MQL | <MQL |
4-MCA | 31 | 28.2 | <MQL | 1.2 | <MQL | <MQL | 0.4 |
UV-P | 72 | 65.5 | <MQL | 9.4 | <MQL | 0.2 | 3.0 |
CDAA | 9 | 8.2 | <MQL | 11.7 | <MQL | <MQL | 2.7 |
EHMC | 6 | 5.5 | <MQL | 0.9 | <MQL | <MQL | 0.2 |
UV-326 | 27 | 24.6 | <MQL | 8.7 | <MQL | <MQL | <MQL |
UV-329 | 7 | 6.4 | <MQL | 1.4 | <MQL | <MQL | 0.5 |
UV-328 | 1 | 0.9 | <MQL | <MQL | <MQL | <MQL | <MQL |
OC | 12 | 10.9 | <MQL | 9.8 | <MQL | <MQL | 2.6 |
DHHB | 16 | 14.6 | <MQL | 0.1 | <MQL | <MQL | <MQL |
BEMT | 3 | 2.7 | <MQL | 0.6 | <MQL | <MQL | <MQL |
EHS | 49 | 44.6 | <MQL | 5.8 | <MQL | <MQL | 4.3 |
HMS | 10 | 9.1 | <MQL | 0.6 | <MQL | <MQL | <MQL |
AVO | 29 | 26.4 | <MQL | 2.7 | <MQL | <MQL | <MQL |
4-OHBP | 1 | 0.9 | <MQL | <MQL | <MQL | <MQL | <MQL |
BP-3 | 12 | 10.9 | <MQL | 0.3 | <MQL | <MQL | <MQL |
BP-8 | 0 | 0 | / | / | / | / | / |
BP-2 | 1 | 0.9 | <MQL | <MQL | <MQL | <MQL | <MQL |
4-MBC | 0 | 0 | / | / | / | / | / |
UV-9 | 0 | 0 | / | / | / | / | / |
BP-1 | 0 | 0 | / | / | / | / | / |
3-BC | 0 | 0 | / | / | / | / | / |
Pretreatment | Numbers of compounds | Sample volume/mL | Solvent volume/mL | Analytical method | MDL/(ng/mL) | Ref. |
---|---|---|---|---|---|---|
LLE | 7 | 1 | 5 | LC-MS/MS | - | [ |
PPT | 6 | 0.1 | 0.1 | LC-MS/MS | 0.08‒0.27 | [ |
DLLME | 4 | 1 | 1 | UHPLC | - | [ |
- | 3 | 0.15 | 0.45 | LC-MS/MS | 1.1‒6.5 | [ |
DLLME | 1 | 1 | 2.7 | GC-AEI-MS/MS | 0.1 | [ |
PPT | 5 | 0.15 | 0.5 | HPLC-MS/MS | 0.1‒0.4 | [ |
PPT+ELR | 22 | 0.05 | 0.4 | UPLC-MS/MS | 0.02‒0.48 | this study |
Table 4 Comparison between this method and the literature methods
Pretreatment | Numbers of compounds | Sample volume/mL | Solvent volume/mL | Analytical method | MDL/(ng/mL) | Ref. |
---|---|---|---|---|---|---|
LLE | 7 | 1 | 5 | LC-MS/MS | - | [ |
PPT | 6 | 0.1 | 0.1 | LC-MS/MS | 0.08‒0.27 | [ |
DLLME | 4 | 1 | 1 | UHPLC | - | [ |
- | 3 | 0.15 | 0.45 | LC-MS/MS | 1.1‒6.5 | [ |
DLLME | 1 | 1 | 2.7 | GC-AEI-MS/MS | 0.1 | [ |
PPT | 5 | 0.15 | 0.5 | HPLC-MS/MS | 0.1‒0.4 | [ |
PPT+ELR | 22 | 0.05 | 0.4 | UPLC-MS/MS | 0.02‒0.48 | this study |
|
[1] | QIAN Jiankun, HE Runming, FANG Ke, LI Chenlong, BAO Shan, GU Wen, TANG Song. Progress in the metabolic and biotransformation of polycyclic aromatic hydrocarbons and their derivatives in humans [J]. Chinese Journal of Chromatography, 2025, 43(6): 571-584. |
[2] | YANG Yanwei, ZHANG Xu, LIN Xiao, SUN Qi, FU Hui, LU Yifu, QIU Tian, ZHANG Zhuona, XIE Linna, ZHANG Haijing, ZHANG Miao, HU Xiaojian, QU Yingli, ZHAO Feng, LYU Yuebin, ZHU Ying, SHI Xiaoming. Quality control strategy for targeted quantitative analysis of chemical pollutants in China National Human Biomonitoring Program [J]. Chinese Journal of Chromatography, 2025, 43(6): 559-570. |
[3] | FENG Zhuangzhuang, LIN Xiao, BAO Dejun, HU Xiaojian, ZHANG Haijing, ZHU Ying, ZHANG Xu. Determination of four oxidative stress biomarkers in human urine using solid-phase extraction coupled with ultra performance liquid chromatography-tandem mass spectrometry [J]. Chinese Journal of Chromatography, 2025, 43(4): 317-325. |
[4] | LIN Qiang, WANG Jian, LI Jingjing, SU Dongxia, LI Meili, WANG Jia, NIU Yumin, SHAO Bing. Determination of 17 perfluorinated/polyfluoroalkyl compounds in serum by high-throughput solid-phase extraction-ultra-high performance liquid chromatography-tandem mass spectrometry [J]. Chinese Journal of Chromatography, 2025, 43(3): 252-260. |
[5] | SHAO Zhiyu, ZENG Jie, DONG Jun, LI Hongxia, YANG Ruiyue, CHEN Wenxiang, WANG Siming. High performance liquid chromatography combined with the 2,2'-dithiodipyridine derivatization reaction for determination of different types of free thiols in human serum and analysis of their relationship with coronary heart disease [J]. Chinese Journal of Chromatography, 2024, 42(4): 352-359. |
[6] | ZHANG Mingye, CAO Yan, LI Xiang, KOU Jing, XU Qitong, YANG Sijie, ZHENG Zhiyi, LIU Jun, MEI Surong. Exposure characteristics and health risk assessment of 97 typical chemical pollutants in human serum [J]. Chinese Journal of Chromatography, 2024, 42(2): 217-223. |
[7] | WANG Zihao, LIANG Fengzhi, CHEN Xuerong, WU Ping, WU Wei. Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry [J]. Chinese Journal of Chromatography, 2024, 42(2): 194-202. |
[8] | SONG Xinqiao, GUO Zehua, LIU Weiwen, ZHA Genhan, FAN Liuyin, CAO Chengxi, ZHANG Qiang. Detection and analysis of moving reaction boundary-based electrophoresis distance using smartphone images [J]. Chinese Journal of Chromatography, 2023, 41(9): 752-759. |
[9] | ZHANG Ruihua, GUO Zehua, ZHANG Qiang, ZHA Genhan, CAO Chengxi, FAN Liuyin, LIU Weiwen. Determination of human serum total protein via electrophoresis titration and capacitively coupled contactless conductivity detection [J]. Chinese Journal of Chromatography, 2023, 41(8): 707-713. |
[10] | ZHANG Huiwen, XIA Huimin, LIU Hong, LIU Yanyan, JIU Xin, ZHANG Minhui, HE Chunlong, WANG Huanyun. Rapid analysis of serum components and metabolites of Sanzi San by high performance liguid chromatography-quadrupole/ electrostatic field orbitrap high resolution mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(7): 653-660. |
[11] | LI Xiang, WANG Limei, SONG Lulu, WAN Zhengce, KOU Jing, ZHANG Mingye, LÜ Yongman, WANG Youjie, MEI Surong. Simultaneous determination of 35 organochlorine pesticides and polychlorinated biphenyls in the serum of the general population in Wuhan by solid phase extraction-gas chromatography-tandem mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(5): 461-468. |
[12] | WANG Mengmeng, XIE Linna, ZHU Ying, LU Yifu. Determination of polybrominated diphenyl ethers in serum using isotope internal standard-gas chromatography-high resolution dual-focus magnetic mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(4): 354-363. |
[13] | WANG Fenglin, YANG Sandong, ZHOU Xinying, FENG Jiao, TANG Tao, LI Tong. Integrated multi-column two-dimensional liquid chromatographic system for determination of amisulpride in serum [J]. Chinese Journal of Chromatography, 2021, 39(2): 197-202. |
[14] | YANG Kaige, WANG Weiwei, WANG Yan, YAN Chao. Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma [J]. Chinese Journal of Chromatography, 2021, 39(11): 1191-1202. |
[15] | ZHAO Furong, GUO Ming, SHAO Dongwei, XIA Qihan. Behavioral imaging of serum albumin during matrine transport based on capillary electrophoresis [J]. Chinese Journal of Chromatography, 2020, 38(8): 975-983. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 89
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 84
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||